why choose us

First received: August 01, 2024

Clinical Trial: A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, NON-RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF PF-07817883 IN ADULT PARTICIPANTS WITH RENAL IMPAIRMENT AND HEALTHY ADULT PARTICIPANTS WITH NORMA

Brief Summary: The purpose of the study is to learn about:how PF-07817883 is processed in the body of adult participants.the safety of PF-07817883.These participants will have different levels of kidney function loss:moderateseverenone or healthy Participants with moderate, severe or no loss of kidney function may be taken into one of 3 groups.This study is seeking for participants who:are male or female of 18 to 90 years of age.have different levels of damage to kidney function or for one of the groups, no damageare willing to…

Read more